Immunovaccine Signs Collaboration to Develop Sustained-Acting, Single Dose Vaccines for Pets

Immunovaccine, Inc. (TSX-V: IMV), a clinical stage vaccine development company focused on advancing its patented DepoVax™ vaccine adjuvanting platform and product candidates, today announced that it has entered into a research collaboration with one of the world’s leading animal health companies to develop next generation companion animal vaccines.

Equals6 Secures $250,000 in Venture Capital Investment

Equals6 has developed a compelling offering that leverages the power of social networking with the very real challenge companies face in finding and engaging the best and brightest graduates looking to start a meaningful career. ~Greg Phipps, Innovacorp 

Halifax company that has built a career development social networking platform for students is enhancing its product and developing new markets with an investment from the province.

Equals6 has secured $250,000 in venture capital financing from Innovacorp.

Student Social Network Equals6 Announces Marketing Idol Competition Winner

Equals6, the professional social network for students, today announced that Hartley Rogers, a commerce student at the University of Winnipeg, has won the Equals6 Marketing Idol competition top prize. Marketing Idol is a business case competition where Equals6 student members tackle real-world business challenges. The company awarded more than $4000 in prizes to the top respondents.

Immunovaccine Inc. Named Best Early-Stage Vaccine Biotech at the 5th Vaccine Industry Excellence Awards

Immunovaccine Inc., a clinical stage vaccine development company focused on advancing its patented DepoVax™ vaccine adjuvanting platform and product candidates for cancer therapy and infectious diseases, announced it was selected as the Best Early-Stage Vaccine Biotech at the 5th Vaccine Industry Excellence (ViE) Awards ceremony during the World Vaccine Congress Washington 2012 in Washington, D.C.

EMSA Improves Billing Record using Siren ePCR Suite

Siren ePCR Suite's accurate data capture (a Medusa Medical Technologies Inc. product) helps the Emergency Medical Services Authority (EMSA) improve their billing system, with only 0.2 per cent of its accounts going to small claims court. While 40-80 per cent of medical bills contain errors, implementing a thoughtfully designed ePCR system such as Siren can result in exceptional numbers such as EMSA's.

Province Invests $2.7 Million for Research Infrastructure through the Nova Scotia Research & Innovation Trust

A recent $2.7 million provincial investment, through the Nova Scotia Research and Innovation Trust (NSRIT), towards eight new cutting-edge research projects will involve upwards of 200 highly qualified people over the next five years. This NSRIT support represents a total value to the Province of Nova Scotia of over $9 million through significant leveraging opportunities.

Seaforth Energy Inc. Secures $2 Million Venture Capital Investment

A leading wind turbine developer and manufacturer will pursue growing opportunities in the global wind energy market after an investment from the province.

Seaforth Energy Inc. has secured $2 million in equity financing from Innovacorp.

"Investing in promising clean technology companies like Seaforth Energy creates good jobs and helps our environment," said acting Economic and Rural Development and Tourism Minister John MacDonell today, March 22. "This investment supports the innovation and competitiveness priorities of jobsHere, our plan to grow the economy."

Pages

Subscribe to Innovacorp RSS